SPRO

Spero Therapeutics, Inc.

NasdaqGS · Healthcare

$2.10

+2.44% today

last filing 2026-06-23Pro sees filings in ~15 min

Price

hover · 4 moves explained

10 sells

Analyst consensus

$4.00target+90.5%vs $2.10 today

Thin coverage · 1 analyst · as of Jul 11. A rough sentiment read — not our forecast or advice.

Earnings

Beat 3 of last 3

Earnings per share · actual vs forecast

Q1 '25+43.8%

−$0.25

exp −$0.44

Q2 '25+92.1%

−$0.03

exp −$0.38

Q3 '25+48.0%

−$0.13

exp −$0.25

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-06-25	Deshpande Milind	Director	—Direct	10,000	—	—
Grant	2026-06-25	Tregoning Kathleen	Director	—Direct	10,000	—	—
Grant	2026-06-25	Smith Cynthia	Director	—Direct	10,000	—	—
Grant	2026-06-25	VINK PATRICK V.J.J.	Director	—Direct	10,000	—	—
Grant	2026-06-25	THOMAS FRANK E	Director	—Direct	10,000	—	—

Grant

Deshpande Milind

Director · 2026-06-25

—

10,000 shares

Grant

Tregoning Kathleen

Director · 2026-06-25

—

10,000 shares

Grant

Smith Cynthia

Director · 2026-06-25

—

10,000 shares

Grant

VINK PATRICK V.J.J.

Director · 2026-06-25

—

10,000 shares

Grant

THOMAS FRANK E

Director · 2026-06-25

—

10,000 shares

22 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →